No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
BIOR240621C1000
- 0.05
- 0.000.00%
15min DelayTrading Jun 13 09:30 ET
0.05High0.05Low
0.05Open0.05Pre Close200 Volume303 Open Interest1.00Strike Price1.00KTurnover291.16%IV45.83%PremiumJun 21, 2024Expiry Date0.00Intrinsic Value100Multiplier8DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.3039Delta1.0916Gamma14.40Leverage Ratio-0.0067Theta0.0000Rho4.38Eff Leverage0.0004Vega
Intraday
- 5D
- 1D
News
Biora Therapeutics Announces Presentation on the BioJet Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
SAN DIEGO, June 11, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (NASDAQ:BIOR), the biotech company that is reimagining therapeutic delivery, today announced that it will present preclinical data from the
Why Ross Stores Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Ross Stores, Inc. (NASDAQ:ROST) rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its first quarter and increased its profit forecast fo
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersCue Health (NASDAQ:HLTH) shares moved upwards by 42.1% to $0.13 during Friday's pre-market session. The company's market cap stands at $21.3 million. Innovative Eyewear (NASDAQ:LUCY) stock rose
Express News | Biora Therapeutics Inc Files for Resale of up to 2.23 Mln Common Shares by the Selling Stockholders - SEC Filing
Express News | Biora Therapeutics Inc Files for Mixed Shelf of up to $200 Mln - SEC Filing
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap Platform at Digestive Disease Week 2024
Four clinical device performance studies successfully demonstrate the NaviCap platform's ability to deliver therapeutics directly to the colon under variable GI conditions and eating schedulesSAN DIEG
Comments
$Biora Therapeutics(BIOR.US$ I was getting some legs getting getting some legs📈
1
Momentum tickers: Should still be slow paced(these are on the scanners)
BIVI(.49) I think has bottomed at .42 - Good adds here at .40s for a run to $1. Has a large gap to $1.76 which is high target. Can use the .42 as a safety for stop loss
BIOR(.70) Filed for mixed shelf offering two weeks ago, been trying to find these…HC Wainwright has $15 Target on it, don’t believe it but I do like it for gap fill to 1.08 minimum. I think this is going to get ran up and offering dropped. Should get dips t...
BIVI(.49) I think has bottomed at .42 - Good adds here at .40s for a run to $1. Has a large gap to $1.76 which is high target. Can use the .42 as a safety for stop loss
BIOR(.70) Filed for mixed shelf offering two weeks ago, been trying to find these…HC Wainwright has $15 Target on it, don’t believe it but I do like it for gap fill to 1.08 minimum. I think this is going to get ran up and offering dropped. Should get dips t...
3
$Biora Therapeutics(BIOR.US$
Don't know who's setting stop losses on a stock like this, but I'm glad they got stopped out today. People often say "I wish I'd bought Apple back in the '80s!" but got no stomach for the days like today, ones that would've scared them out before Apple became a juggernaut.
Don't know who's setting stop losses on a stock like this, but I'm glad they got stopped out today. People often say "I wish I'd bought Apple back in the '80s!" but got no stomach for the days like today, ones that would've scared them out before Apple became a juggernaut.
5
Read more